Marketing - Press Releases

Date	Title	Company
02-Dec-2020	Teckro Expands Product Portfolio to Unblock Clinical Research Site Staff	Teckro
02-Dec-2020	UK HEALTHTECH START-UP CERA REACHES $120M REVENUE RUN-RATE IN LESS THAN FOUR YEARS, CONFIRMS 5,000 NEW ROLES NATIONWIDE	Cera
02-Dec-2020	UK set to take advanced therapies and vaccine manufacturing industry to the next level: the Advanced Therapy Skills Training Network launches today – driven by industry and coordinated by the Cell and Gene Therapy Catapult	Cell and Gene Therapy Catapult
02-Dec-2020	BioInnovation Institute takes in new cohort of promising early-stage innovations	BioInnovation Institute (BII),
02-Dec-2020	Boehringer Ingelheim: Digital Lab BI X Facilitates Global Partnerships	Boehringer Ingelheim
02-Dec-2020	iRhythm Technologies Receives Positive National Guidance in First of its Kind Digital Health Pilot with National Institute for Health and Care Excellence	iRhythm Technologies, Inc.
02-Dec-2020	DuPont Brings Science-backed Quality and Innovation to Asia’s Pharmaceutical Industry at CPhI China 2020	DuPont
02-Dec-2020	ViiV Healthcare and the Medicines Patent Pool expand access to dolutegravir-based regimens for people living with HIV in Azerbaijan, Belarus, Kazakhstan and Malaysia with innovative new licensing agreement	ViiV Healthcare
02-Dec-2020	GBT Initiates Early Access Program for Voxelotor in Patients with Sickle Cell Disease in Europe and Other Regions Outside the United States	Global Blood Therapeutics, Inc.
02-Dec-2020	UK’s largest ever NHS rare disease diagnosis programme launched by Mendelian and Modality NHS Partnership	Mendelian
02-Dec-2020	Nanoform makes US TV debut in Advancements with Ted Danson (CNBC)	Nanoform Finland Plc
02-Dec-2020	BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years	BD (Becton, Dickinson and Company)
01-Dec-2020	European Commission Authorises Janssen’s TREMFYA®▼ (guselkumab), a First-in-Class Treatment for Active Psoriatic Arthritis (PsA)	Janssen
30-Nov-2020	PTC Therapeutics Announces Initiation of Global Phase 3 Clinical Trial to Evaluate Vatiquinone in Friedreich Ataxia	PTC Therapeutics, Inc.
30-Nov-2020	Pandemic to delay cancer advances by nearly 18 months, researchers fear	The Institute of Cancer Research
30-Nov-2020	Dupixent® (dupilumab) approved by European Commission as first and only biologic medicine for children aged 6 to 11 years with severe atopic dermatitis	Sanofi
30-Nov-2020	Khondrion shares progress of sonlicromanol development programme at Mitochondrial Medicine 2020 virtual conference	Khondrion
27-Nov-2020	Sharing the evidence to help tackle COVID-19	The University of Huddersfield
27-Nov-2020	UK TECH SPINOUT SALIENT BIO LAUNCHES FASTEST EVER ROBOTIC COVID-19 PCR-BASED TESTS WITH A GOLD STANDARD ACCURACY OF OVER 99%	Salient Bio
27-Nov-2020	Nanoform launches technology for biologics and sets new near-term business target for 2021	Nanoform Finland Plc